Cardiac Troponin Market, By Troponin Type (Cardiac Troponin I and Cardiac Troponin T), By Product Type (Reagents and Kits, Calibrators and Controls, and Consumables and Accessories), By Test Format (Laboratory-Based Troponin Tests and Point-of-Care Troponin Tests), By Sample Type (Whole Blood, Serum, and Plasma), By Assay Sensitivity (Conventional/Standard Sensitivity Troponin Assays, and High-Sensitivity Troponin Assays), By Technology Platform (Chemiluminescence Immunoassays, Enzyme-Linked Immunosorbent Assays, Fluorescence Immunoassays, Immunochromatographic Assays, Electrochemical Immunoassays, and Other immunoassay methods), By Clinical Application (Acute Myocardial Infarction Diagnosis, Acute Coronary Syndrome Risk Stratification, Myocardial Injury Monitoring (Non-AMI Causes), and Prognostic and Outcome Assessment), By Turnaround Time (Rapid Tests (<30 minutes) and Standard Tests (≥30 minutes)), By Age Group (Adult Population and Geriatric Population), By End User (Hospitals, Diagnostic Laboratories, Emergency Care Centers, Cardiac Specialty Clinics, Ambulatory Care Centers, and Research and Academic Institutes), By Distribution Channel (Online and Offline), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)